Evidence for marked eosinophil degranulation in a case of eosinophilic pneumonia.
Jorens
P G
PG
Department of Respiratory Medicine, University Hospital of Antwerp, Belgium.
Van Overveld
F J
FJ
Van Meerbeeck
J P
JP
Van Alsenoy
L
L
Gheuens
E
E
Vermeire
P A
PA
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D015550:Cell Degranulation; D047091:Eosinophil Granule Proteins; D047208:Eosinophil-Derived Neurotoxin; D004804:Eosinophils / Q000502:physiology*; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011657:Pulmonary Eosinophilia / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D012260:Ribonucleases
D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D018836:Inflammation Mediators; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases; D008775:Methylprednisolone